Candel Therapeutics

-$0.22 (-2.23%) As of 7:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.

About CADL

Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene.

CEO
Paul-Peter Tak
Employees
—
Headquarters
Needham, Massachusetts
Founded
2002

CADL Key Statistics

Market Cap
276.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
31.89K
High Today
$9.89
Low Today
$9.54
Open Price
$9.89
Volume
6.10K
52 Week High
$14.78
52 Week Low
$5.51

CADL Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 15, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure